Drug Development Immunization White Paper 
Pharmaceutical Technology
DECEMBER 7, 2022
A Phase II study of the pharmacodynamic effects of semorinemab (RG 6100), an investigational drug being developed by Roche and AC Immune, on plasma and cerebrospinal fluid (CSF) also took into account plasma and CSF p-tau levels to determine individuals’ response to treatment. Please check your email to download the Report.
Pharmaceutical Technology
DECEMBER 7, 2022
A Phase II study of the pharmacodynamic effects of semorinemab (RG 6100), an investigational drug being developed by Roche and AC Immune, on plasma and cerebrospinal fluid (CSF) also took into account plasma and CSF p-tau levels to determine individuals’ response to treatment. Please check your email to download the Report.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 28, 2023
Biocytogen’s independently developed bispecific antibody, YH008, exerts antagonistic and agonistic activities. It was engineered with an Fc-silent IgG1 isotype to avoid activation of Fc-receptor-mediated non-specific immune. It also activated tumour-infiltrating DCs and T cells in vivo pharmacodynamic studies.
Pharmaceutical Technology
MARCH 9, 2023
UCB4594 targets the immune checkpoint, human leukocyte antigen G, which is also called HLA-G. Under the partnership, the Centre for Drug Development of Cancer Research UK will appoint the chief clinical and scientific investigators.
Pharmaceutical Technology
FEBRUARY 1, 2023
Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind. Since the FDA approved AstraZeneca’s monoclonal antibody therapy Synagis (palivizumab) 25 years ago, drug development successes for RSV have been few and far between.
Pharmaceutical Technology
JUNE 18, 2025
Reports Use of Artificial Intelligence in Pharmaceutical Drug Development a. fired 17 sitting members of the Advisory Committee on Immunization Practices at the Centers for Disease Control and Prevention (CDC), concerns rose about the stance of federal agencies on vaccines. Find out more Sign up for our daily news round-up!
Pharmaceutical Technology
MARCH 24, 2023
In light of World TB day on March 24, the field hopes to overcome some major barriers to the drug development landscape. Unfortunately, lack of funding and resources remain an obstacle within the TB field for developing new vaccines. The BCG vaccine is a live-attenuated virus vaccine.
Expert insights. Personalized for you.
105 
Let's personalize your content